SFV particles expressing the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibited tumor growth, reduced tumor angiogenesis, and prevented metastatic spread in immunized BALB/c mice [139]. This evidence concerns the gene KDR and neoplasm.